It is worthy to note that, based on the immunohistochemical staining of two tissue microarrays, results verified again that average ANXA1 immunostaining scores were significantly higher in GBM than in low‐grade gliomas (LGG) or normal tissues (Figure 1D). This evidence concerns the gene ANXA1 and central nervous system cancer.